Ping Zhang, currently Senior Vice President of Global Industrial Affairs at Hepalink, CEO OF Cytovance bio,holds an MBA degree and international work and study experience. Previously, he served as the Head of Sanofi Industrial Affairs in China, responsible for Sanofi's industrial operations in China, and led the implementation of several new products and group product transfer projects in China. Prior to that, he worked for Xi 'an Janssen Pharmaceutical Company, one of the first foreign-invested enterprises in China. Zhang Ping has more than 30 years of experience in drug production management in foreign-funded enterprises and has obtained the first Six Sigma Black belt certification in China.